In summary, the present data indicate that local mutations in the jun and fos family genes are qualified to modify the transactivation activity of the resulting AP-1 complexes and presumably contribute to particular pro-inflammatory/pro-destructive characteristics and disease progression in individual RA patients [63]. Here, FOS is linked to rheumatoid arthritis.